Paterson Beverley J, Durrheim David N
Hunter Medical Research Institute, Newcastle, NSW, Australia.
Commun Dis Intell Q Rep. 2013 Jun 30;37(2):E149-55. doi: 10.33321/cdi.2013.37.21.
With eradication almost within reach, the importance of detecting every poliomyelitis case has taken on additional significance. The selected surveillance strategy must be effective and efficient. A review of polio surveillance in Australia was conducted to consider whether current strategies were optimal. Document review and semi-structured key informant interviews were used to conduct the review. Interviews were recorded, transcribed and thematically analysed. The review was an iterative process with feedback on the findings sought from interviewees. Since Western Pacific Regional polio-elimination status was certified, one imported adult case was detected in 2007 in Australia, with no evidence of further transmission, and no Australian paediatric cases identified. Respondents reported that: it was not possible to prevent importations; paediatric cases were more likely to be identified than adult cases; and there may be a low level of suspicion among clinicians. Case detection and outbreak mitigation were considered key reasons to undertake polio surveillance. While Australia has not achieved one of the key World Health Organization (WHO) surveillance targets, this did not compromise Australias polio-free status. Identified issues with polio surveillance were the potential for an importation with high attendant investigation and containment costs, low stool sample collection rates, and the opportunity to improve safeguards around the importation and laboratory storage of biological samples containing poliovirus. The review found strong support for ongoing polio surveillance, particularly to detect imported cases and to demonstrate commitment to maintaining a polio-free region. Existing polio surveillance strategies were considered appropriate for Australia.
随着根除工作几乎触手可及,发现每一例脊髓灰质炎病例的重要性又有了额外的意义。所选的监测策略必须既有效又高效。对澳大利亚的脊髓灰质炎监测进行了一次审查,以考量当前策略是否最佳。审查采用了文件回顾和对关键信息提供者进行半结构化访谈的方式。访谈进行了录音、转录并进行了主题分析。审查是一个迭代过程,会向受访者寻求关于调查结果的反馈。自西太平洋区域获得无脊髓灰质炎认证以来,2007年在澳大利亚发现了一例输入性成人病例,没有进一步传播的迹象,也未发现澳大利亚的小儿病例。受访者报告称:无法预防输入病例;小儿病例比成人病例更有可能被发现;临床医生的怀疑程度可能较低。病例发现和疫情缓解被认为是开展脊髓灰质炎监测的关键原因。虽然澳大利亚尚未实现世界卫生组织(WHO)的一项关键监测目标,但这并未损害澳大利亚的无脊髓灰质炎状态。脊髓灰质炎监测中发现的问题包括:输入病例可能带来高昂的调查和控制成本、粪便样本采集率低,以及有机会加强对含有脊髓灰质炎病毒的生物样本的输入和实验室储存的保障措施。审查发现,各方大力支持持续开展脊髓灰质炎监测,特别是为了发现输入病例并表明致力于维持无脊髓灰质炎区域。现有的脊髓灰质炎监测策略被认为适用于澳大利亚。